Doi.org/10.1111/gbb.12373

Target Article

Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566  ; Robert M J Deacon M J Hurley C M Rebolledo M Snape F J Altimiras L Farias M Pino R Biekofsky ; NULL; 02/17/2017; https://doi.org/10.1111/gbb.12373

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.